Advocacy in Action

Here is a quick run down of major issues being discussed by policymakers from an endocrine perspective and the Society’s current advocacy work. Let us know if you would like additional information or have any questions.

Capitol Hill

What's Happening in Washington

Take Action

The Endocrine Society is hard at work advocating Congress to increase funding for NIH and Title X in FY2020 and reauthorize the Special Diabetes Program.

It is critical that all members of Congress hear from YOU about why these issues are important!

Join our campaigns today!

Support funding for NIH

Support funding for Reproductive and Preventive Health Care

Special Diabetes Program

Democrats & Republicans Prepare to Face Off on Appropriations – When lawmakers return to Capitol Hill on September 9, they'll have just 15 legislative days to reach bicameral agreement on the appropriations bills before the September 30 deadline, and the Senate still needs to move its bill through subcommittees and the full committee before negotiating with House appropriators in conference.  Congressional analysts have noted that there is still a risk of a government shutdown this fall, even as Congress works to reach a bicameral compromise.  Several reasons contribute to the risk of government shutdown:  1) the aforementioned serious time crunch once the summer break comes to an end; 2)border wall funding continues to be a sticking point – as you will recall, funding for the border wall was the cause of the last shutdown; and 3) the so-called “poison pill” riders, a series of controversial, partisan policies ranging from abortion to tariffs that could be attached to the appropriations bill.

What We are Working On

Bracing for the September Storm – While Congress continues its August recess, we are bracing for a busy legislative September:

  • Online Advocacy Campaigns – Now is a great time to contact Congress and urge support for biomedical research funding, access to women’s health, and renewal of the Special Diabetes Program.  If you have not done so already, please join our campaigns today!
  • Physician Payment – We will be presenting at CEU Miami on September 7th at 7am about the latest proposed changes to Medicare physician payment, including Evaluation & Management codes and the Quality Payment Program.
  • Congressional Public Health Fair – We will be participating in the 5th annual Congressional Public Health Fair on September 12th to help educate Congress about various public health policy opportunities.  Our booth will focus on endocrine-disrupting chemicals and encourage support for new cosmetic safety legislation to allow the Food and Drug Administration to regulate the ingredients in personal care products.
  • Rally for Medical Research Hill Day – We are a sponsor of the Rally for Medical Research Hill Day on September 19th and will be joining hundreds of researchers to call on Congress to increase funding for the National Institutes of Health.
    Clinical Hill Day – We are planning a Clinical Hill Day on September 23rd to advocate to Congress about renewing the Special Diabetes Program, addressing the insulin pricing situation, and creating new opportunities for endocrinology in telehealth.

Latest Endocrine Society Policy Communications

Endocrine Society Comments on Section 1557 Rule – We expressed concerns to the Department of Health and Human Services over the administration's proposed revisions to the non-discrimination provisions set forth in Section 1557 of the Affordable Care Act, which protect transgender individuals from discrimination. 

Letter to European Commission President-Elect - We congratulated Dr. Ursula von der Leyen on her election to the Presidency of the European Commission and highlighted our shared priorities in public health and environmental toxicology, including endocrine-disrupting chemicals.

Letter to National Institute on Aging - We commented on the development of the new NIA Longitudinal Rat Resource to study neural and behavioral trajectories of cognitive aging.  Our comments identified considerations relevant to behavioral assessment, measurement parameters of interest to endocrine scientists, general data management recommendations, and overarching considerations for the resource.